Table 2.

Responses from Korean Doctors on Postpolypectomy Follow-up Surveillance Recommendations in Comparison to Guideline Recommendations

Clinical scenario	Recommendation in Korean guidelines, yr	Responses on follow-up surveillance intervals
		6 mo	1 yr	3 yr	5 yr	10 yr	No repetition
6-mm Hyperplastic polyp	5*	1 (0.2)	33 (7.0)	124 (28.9)	210 (61.1)	9 (2.7)	1 (0.2)
6-mm TA	5†	4 (0.7)	117 (26.9)	182 (48.6)	71 (23.5)	1 (0.3)	0
12-mm TA with HGD	3	163 (34.1)	168 (49.4)	44 (15.8)	2 (0.7)	0	0
12-mm TVA	3	99 (20.2)	191 (48.4)	84 (30.3)	3 (1.0)	0	0
Two 6-mm TAs	5†	13 (2.2)	150 (31.8)	157 (47.3)	55 (18.3)	1 (0.4)	0
No polyps in a patient with a 12-mm TA 3 yr earlier	5*	2 (0.4)	18 (3.2)	159 (41.4)	196 (52.9)	3 (2.1)	0

Data are presented as unweighted numbers (weighted proportions). Non-respondents to each question were excluded.

TA, tubular adenoma; HGD, high-grade dysplasia; TVA, tubulovillous adenoma.

^*The U.S. Multi-Society Task Force recommends an interval of 10 years; the European panel (EPAGE II) recommends 5.5 years;

^†The U.S. Multi-Society Task Force recommends an interval of 5–10 years; the European panel (EPAGE II) recommends 5 years.